摘要:
The invention relates to a collimator (1) for defining a beam of energetic rays (2) which is emitted from an essentially punctiform radiation source (3) and is oriented onto an object (1) to be treated. The collimator is especially used for the stereotactic conformation radiotherapy of tumors. The collimator (1) is embodied in such a way that an irregular object (4) can be scanned by rays (2, 2′) which are defined by an opening in the collimator. The invention also relates to a program for controlling the collimator. In order to define the contours (29, 29′, 29″) of the objects (4) to be irradiated in a simple but highly accurate manner, especially with a precise definition of the irradiation fields, the collimator comprises a plurality of different sized openings (5, 5′ 5″). One of the openings (5, 5′, 5″) can be selectively displaced in a polydirectional manner on a strip (6) having a spherical surface, and the central axis (7) thereof is oriented towards the radiation source (3). The other collimator openings (5′, 5″) are shielded form the rays (2). A control system (9) acts on the drives (23, 24, 25) of a drive device (8) in such a way that large openings (5, 5′) are used to scan large irradiation surfaces (26) of the object to be treated (4), and small openings (5′, 5″) are used for precise definition at the edge of the irradiation surfaces (26) of the object to be treated (4), especially in the event of irregular contours (29, 29′, 29″).
摘要:
A method of intensity-modulating a beam of radiation from a radiation source is provided, the method including the steps of: a) providing a collimator having a window which allows the passage of radiation from the radiation source and which defines when viewed from the radiation source a two-dimensional array of bixels, the collimator further having a plurality of independently movable radiation attenuators which are constrained to move along columns or rows of the array to block selected bixels thereof, whereby, within each column or row along which the attenuators are movable, at least one arrangement of the respective attenuator(s) results in a pair of open bixels sandwiching a blocked bixel or line of blocked bixels; b) positioning the collimator in the path of the radiation source; and c) repeatedly: positioning the radiation attenuators within the window to form at each repeat a different pattern of bixels; and irradiating the collimator, until a predetermined pattern of radiation intensities for the beam of radiation has been delivered through the collimator. A corresponding apparatus for producing an intensity-modulated beam of radiation which is operable in accordance with the above method, and a method of radiotherapy treatment performed on a human or animal body comprising subjecting the body to an intensity-modulated beam of radiation formed using the above method are also provided.
摘要:
The present invention provides an oligonucleotide which is capable of activating RIG-I and inducing an anti-viral, in particular, an IFN, response in cells expressing RIG-I. The present invention further provides an oligonucleotide which is capable of activating RIG-I and which has target gene-silencing activity. The oligonucleotide of the present invention has a double-stranded section of at least 19, preferably at least 21 bp, at least one 5′ triphosphate, and at least one blunt end which bears a 5′ triphosphate. The present invention further provides the use said oligonucleotide for inducing an anti-viral, in particular, an IFN, response in vitro and in vivo. The present invention additionally provides the use of said oligonucleotide for preventing and/or treating diseases or conditions such as infections, tumors/cancers, and immune disorders.
摘要:
Methods and compositions are provided for extending the clinical utility of IFN-α in the treatment of a variety of viral and proliferative disorders. Among other aspects, the invention provides methods which increase the efficacy of IFN-α treatment and reduce IFN-α treatment-related side effects. In addition, methods are provided for supporting the survival and for activating natural interferon producing cells (IPCs) in vitro without exogenous IL-3 or GM-CSF. The invention is based on the discovery that certain CpG and non-CpG ISNAs promote survival and stimulation of IPCs.
摘要:
An apparatus (1) and a method serve for precision rolling of a surface area (2) of a rotationally symmetrical component (3), especially a screw. The apparatus (1) includes at least two spaced apart rolling tools (4, 5), a measuring unit (9) for determining an actual blank diameter of the component (3), an evaluating unit (10) for comparing the determined actual blank diameter of the component (3) with a predetermined blank diameter and for determining an adjustment value from the result of the comparison, and a control unit (11) for adjusting a distance between the at least two rolling tools (4, 5) in response to the adjustment value.
摘要:
A method for operation of an ion beam therapy system that comprises a grid scanner device, arranged in a beam guidance system (6, 8), having vertical deflection means (13) and horizontal deflection means (14) for the vertical and horizontal deflection of a treatment beam (11) perpendicular to its beam direction, with the result that the treatment beam (11) is deflected by the grid scanner device to an isocentre (10) of the irradiation site and scans a specific area surrounding the isocentre (10) using a specific radiation dose. Both the depth dose distribution and the transverse dose distribution of the grid scanner device (13, 14) at various positions in the region of the isocentre (10) are measured and evaluated, it being concluded that the radiation dose distribution is adequately homogeneous if the degree of variation in the radiation dose values measured at the individual positions does not exceed a specific tolerance limit value.
摘要:
The present invention relates to a method of checking an isocentre and a patient-positioning device of an ion beam therapy system that comprises a grid scanner device, arranged in a beam guidance system, having vertical deflection means and horizontal deflection means for the vertical and horizontal deflection of a treatment beam perpendicular to its beam direction, with the result that the treatment beam is deflected by the grid scanner device onto an isocentre of the irradiation site, and a specific area surrounding the isocentre is scanned, wherein a check of the isocentre and a patient-positioning device is carried out and the patient-positioning device comprises a patient table rotatable about an axis of rotation of the table. For the checking, a target point within a spherical phantom is represented by means of a special specimen body and the centre point of the specimen body is visibly represented by means of several image-forming methods. On departure of the measurement results in respect of the spatial position of the centre point under the image-forming methods from a predetermined intervention threshold, the ion beam therapy system is subjected to an inspection and/or maintenance.
摘要:
Tis invention provides oligonucleotide agents that modulate an immune response by stimulating IFN production and methods of using such agents for therapeutic treatments of mammals.
摘要:
The invention describes a method of determining whether a double stranded RNA (dsRNA) silences gene expression in a cell in vivo by an RNA interference (RNAi) mechanism by performing 5′-rapid amplification of cDNA ends (5′RACE) to detect the cleavage site of the mRNA in the RNA sample.
摘要:
The present invention provides an oligonucleotide which is capable of activating RIG-I and inducing an anti-viral, in particular, an IFN, response in cells expressing RIG-I. The present invention further provides an oligonucleotide which is capable of activating RIG-I and which has target gene-silencing activity. The oligonucleotide of the present invention has a double-stranded section of at least 19, preferably at least 21 bp, at least one 5′ triphosphate, and at least one blunt end which bears a 5′ triphosphate. The present invention further provides the use said oligonucleotide for inducing an anti-viral, in particular, an IFN, response in vitro and in vivo. The present invention additionally provides the use of said oligonucleotide for preventing and/or treating diseases or conditions such as infections, tumors/cancers, and immune disorders.